| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 2012 | Oct 17, 2012 | DYNAVAX TECHNOLOGIES CORP | Director | Sell | 2.5 | -6,000,000 | -66.43% | ✓ | $28.4M |
| Jul 20, 2009 | Jul 22, 2009 | Oncotelic Therapeutics, Inc. | Director | Buy | 100.0 | +10,000,000 | 58.42% | ✗ | $12.5M |